Ercc1 Expression is Associated with Response to Gemox Plus Erlotinib in Pancreatic Adenocarcinoma Patients

Autor:	Judith Stift, Thorsten Füreder, Nadja Stranzl, Werner Scheithauer, Gabriela Kornek, Julia Klech, Irene Kührer
Rok vydání:	2013
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine Adenocarcinoma Hematology Erlotinib GemOx medicine.disease business medicine.drug
Zdroj:	Annals of Oncology. 24:iv80
ISSN:	0923-7534
DOI:	10.1093/annonc/mdt203.153
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::937f469232655358cca9632bf10781b1 https://doi.org/10.1093/annonc/mdt203.153 Zobrazit plný text záznamu